Fact sheet: Fidelity Gbl Health Care

Fund information

Fund name
Fidelity Global Health Care W GBP
Fund company manager
Fidelity International (FIL In
Fund type
SIB
Fund manager
Alex Gold
since 30/06/2017
Fund objective
Aims to provide long-term capital growth with the level of income expected to be low. At least 70% invested in the shares of companies throughout the world that are involved in the design, manufacture, or sale of products and services used in health care, medicine or biotechnology. Has the freedom to invest outside the fund's principal geographies, market sectors, industries or asset classes. May invest in assets directly or achieve exposure indirectly through other eligible means including derivatives. Can use derivatives with the aim of risk or cost reduction or to generate additional capital or income, including for investment purposes, in line with the fund’s risk profile. The fund has discretion in its choices of investments within its objectives and policies. Income is accumulated in the share price. Shares can usually be bought and sold each business day of the fund. This fund may not be appropriate for investors who plan to sell their shares in the fund within 5 years. Investment in the fund should be regarded as a long-term investment.
Benchmark
MSCI AC World Health Care
Investment style
Growth
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

5.22 %

1 Year rank in sector

-

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 749.0 m

FE Risk score

121

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    65.9%
  • Australia
    5%
  • Denmark
    4.9%
  • Switzerland
    4.2%
  • UK
    3.4%
  • Health Care
    95.5%
  • Money Market
    2.3%
  • Consumer Discretionary
    2.1%
  • Financials
    0.1%
  • US Equities
    65.9%
  • Australian Equities
    5%
  • Danish Equities
    4.9%
  • Swiss Equities
    4.2%
  • UK Equities
    3.4%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-2.18 %8.91 %5.22 %61.3 %127.31 %
Sector1.98 %12.69 %10.38 %31.15 %105.72 %
Rank within sector / / / / /
Quartile th th th th th th

Calendar performance

YTD-20172016201520142013
Fund11.24 %5 %13.1 %29.06 %30.73 %
Sector15.76 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector / / / / /
Quartile th th th th th th

Risk statistics

Alpha11.2
Beta0.59
Sharpe0.94
Volatility13.67
Tracking error12.38
Information ratio0.59
R-Squared0.44

Price movement

52 week high1.667
52 week low1.375
Current bid price0
Current offer price0
Current mid price1.613

Holdings by region

  • 65.9% USA
  • 5% Australia
  • 4.9% Denmark
  • 4.2% Switzerland
  • 3.4% UK
  • 3.2% Germany
  • 3.2% Japan
  • 2.7% France
  • 2.3% Money Market
  • 2.1% China

Holdings by sector

  • 95.5% Health Care
  • 2.3% Money Market
  • 2.1% Consumer Discretionary
  • 0.1% Financials

Holdings by asset type

  • 65.9% US Equities
  • 5% Australian Equities
  • 4.9% Danish Equities
  • 4.2% Swiss Equities
  • 3.4% UK Equities
  • 3.2% German Equities
  • 3.2% Japanese Equities
  • 2.7% French Equities
  • 2.3% Money Market
  • 2.1% Chinese Equities

Individual holdings

  • 8.9% JOHNSON & JOHNSON
  • 4.8% MERCK & CO INC(NEW)
  • 4.8% UNITEDHEALTH GROUP INC
  • 4.5% MEDTRONIC PLC
  • 4.2% ROCHE HLDG AG
  • 3.7% ABBOTT LABORATORIES
  • 3.2% FRESENIUS MEDICAL CARE AG & CO.KGAA
  • 3.2% LILLY (ELI) & CO
  • 3.1% CSL
  • 2.8% NOVO-NORDISK AS